Similar articles for PMID: 22395475

Year	Number of Results
1994	1
1998	1
1999	1
2000	2
2001	2
2002	2
2003	1
2004	3
2006	5
2007	4
2008	8
2009	10
2010	5
2011	6
2012	16
2013	11
2014	8
2015	4
2016	7
2017	6
2018	3
2019	5
2020	6
2021	4
2022	7
2023	2
2024	0

1

Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.

Andreasson A, Sulaiman L, do Vale S, Martins JM, Ferreira F, Miltenberger-Miltenyi G, Batista L, Haglund F, Björck E, Nilsson IL, Höög A, Larsson C, Juhlin CC. Andreasson A, et al. Fam Cancer. 2012 Sep;11(3):355-62. doi: 10.1007/s10689-012-9520-z. Fam Cancer. 2012. PMID: 22395475

2

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Juhlin CC, Nilsson IL, Johansson K, Haglund F, Villablanca A, Höög A, Larsson C. Juhlin CC, et al. Endocr Pathol. 2010 Sep;21(3):166-77. doi: 10.1007/s12022-010-9121-z. Endocr Pathol. 2010. PMID: 20473645

3

Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.

Juhlin CC, Kiss NB, Villablanca A, Haglund F, Nordenström J, Höög A, Larsson C. Juhlin CC, et al. PLoS One. 2010 Mar 1;5(3):e9472. doi: 10.1371/journal.pone.0009472. PLoS One. 2010. PMID: 20208994 Free PMC article.

4

Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

Rohlin A, Engwall Y, Fritzell K, Göransson K, Bergsten A, Einbeigi Z, Nilbert M, Karlsson P, Björk J, Nordling M. Rohlin A, et al. Oncogene. 2011 Dec 15;30(50):4977-89. doi: 10.1038/onc.2011.201. Epub 2011 Jun 6. Oncogene. 2011. PMID: 21643010 Free PMC article. Clinical Trial.

5

Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.

Sulaiman L, Juhlin CC, Nilsson IL, Fotouhi O, Larsson C, Hashemi J. Sulaiman L, et al. Epigenetics. 2013 Jun;8(6):646-55. doi: 10.4161/epi.24823. Epub 2013 Jun 13. Epigenetics. 2013. PMID: 23764768 Free PMC article.

6

Molecular Characteristics of Large Parathyroid Adenomas.

Agarwal A, Pradhan R, Kumari N, Krishnani N, Shukla P, Gupta SK, Chand G, Mishra A, Agarwal G, Verma AK, Mishra SK. Agarwal A, et al. World J Surg. 2016 Mar;40(3):607-14. doi: 10.1007/s00268-015-3380-2. World J Surg. 2016. PMID: 26669787

7

Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.

Segditsas S, Sieber OM, Rowan A, Setien F, Neale K, Phillips RK, Ward R, Esteller M, Tomlinson IP. Segditsas S, et al. Exp Mol Pathol. 2008 Dec;85(3):201-6. doi: 10.1016/j.yexmp.2008.09.006. Epub 2008 Oct 11. Exp Mol Pathol. 2008. PMID: 18977219

8

CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort.

Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, Maiello E, D'Agruma L, Chiodini I, Clemente C, Minisola S, Romagnoli E, Corbetta S, Viti R, Eller-Vainicher C, Spada A, Iacobellis M, Malavolta N, Carella M, Canaff L, Hendy GN, Cole DE, Scillitani A. Guarnieri V, et al. Cell Oncol (Dordr). 2012 Dec;35(6):411-22. doi: 10.1007/s13402-012-0100-x. Epub 2012 Sep 18. Cell Oncol (Dordr). 2012. PMID: 22987117

9

Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.

Ciuffi S, Cianferotti L, Nesi G, Luzi E, Marini F, Giusti F, Zonefrati R, Gronchi G, Perigli G, Brandi ML. Ciuffi S, et al. Endocr J. 2019 Apr 25;66(4):319-327. doi: 10.1507/endocrj.EJ18-0387. Epub 2019 Feb 22. Endocr J. 2019. PMID: 30799315 Free article.

10

Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.

Hosny Mohammed K, Siddiqui MT, Willis BC, Zaharieva Tsvetkova D, Mohamed A, Patel S, Sharma J, Weber C, Cohen C. Hosny Mohammed K, et al. Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):731-735. doi: 10.1097/PAI.0000000000000378. Appl Immunohistochem Mol Morphol. 2017. PMID: 27490759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year